Effects of Mitomycin C in Early Conjunctival Inflammation after Pterygium Surgery
Purpose: The purpose of this study was to compare inflammatory events and graft characteristics 1 month and 6 months after conjunctival limbal autograft (CLAU) with and without intraoperative mitomycin C (MMC). Methods: This study included 69 eyes of 69 patient's eyes with pterygium. Clinical d...
Gespeichert in:
| Veröffentlicht in: | Current eye research 2017-05, Vol.42 (5), p.696-700 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 700 |
|---|---|
| container_issue | 5 |
| container_start_page | 696 |
| container_title | Current eye research |
| container_volume | 42 |
| creator | da Costa Paula, Claudia Julio, Gemma Campos, Pamela Pujol, Pere Asaad, Mouafk |
| description | Purpose: The purpose of this study was to compare inflammatory events and graft characteristics 1 month and 6 months after conjunctival limbal autograft (CLAU) with and without intraoperative mitomycin C (MMC).
Methods: This study included 69 eyes of 69 patient's eyes with pterygium. Clinical data concerning patient demography, preoperative examination including pterygium morphology, recurrence clinical assessment, and complications after CLAU with (MMC+) and without (MMC−) intraoperative MMC were all registered at 1 month and 6 months after surgery.
Results: Thirty-five eyes were included in MMC+ and 34 in MMC−. Preoperative data were similar in both groups (Student's t test and Fisher's exact test; p > 0.05).
Thirty-four (49.6%) eyes in the whole sample showed at least one inflammatory complication at 1 month after surgery. MMC− group showed a significantly higher number of cases with complications (p < 0.001; Chi
2
test) (MMC+ 28.5%; MMC− 70.5%). No patients presented clinical recurrence at 1 month after surgery. The examination revealed a higher incidence of clinical hyperemia surrounding the surgical site and graft contraction on the host site on the MMC− group, both with statistical signification (p < 0.001; Chi
2
test). Although the hemorrhages were less frequent in the MMC− group, there were no significant differences between the two groups (p > 0.05; Chi
2
test). Pyogenic granuloma developed at the surgical site in three eyes (4.37%), two of those granulomas were at the MMC− group (p > 0.05).
Tendency for recurrences was significantly different between both groups (p = 0.0001; Fisher's exact test) at the end of 6 months. Thirteen (38%) eyes showed recurrence in MMC− and no cases were displayed in MMC+. Presence of at least 1 inflammatory event was only seen in 16 (23%) cases, all of them in MMC−. Specifically, 15 (44%) eyes showed hyperemia and one (3%) eye presented conjunctival hemorrhages. No new cases of pyogenic granuloma or graft contraction were seen at this time point in both groups. Hyperemia was the only specific event with significant differences between MMC− and MMC+ (p = 0.0001; Fisher's exact test) at 6 months after surgery.
Conclusion: The eyes receiving intraoperative MMC after CLAU seem to present less hyperemia and graft contraction after surgery than those that did not receive MMC as an adjuvant factor. Intraoperative MMC could be associated with a lower recurrence rates. |
| doi_str_mv | 10.1080/02713683.2016.1236965 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_XX2</sourceid><recordid>TN_cdi_csuc_recercat_oai_recercat_cat_2072_270252</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1841135512</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-b4887391468d9355a8d3e3efd4d2e61d3c83af60824147e0404dd308b49e25303</originalsourceid><addsrcrecordid>eNp9kUtv1DAUhS0EotOWn9DKSzaZXr8Szw40GmilVoAoa8vjR-UqiYvtgPLvcTRTuuvC1w99594jH4QuCKwJSLgC2hHWSramQNo1oazdtOINWhHeQkMp0LdotTDNAp2g05wfAZYH_h6d0E4KTjhdoR87750pGUeP70KJw2zCiLe4lp1O_Yy3cXycRlPCH93jm9H3ehh0CXHE2heX8Pda5ocwDfjnlB7q-Ry987rP7sNxP0O_vuzut9fN7bevN9vPt43hQpRmz6Xs2KbalXbDhNDSMsect9xS1xLLjGTatyBpNdo54MCtZSD3fOOoYMDOEDn0NXkyKjnjktFFRR1eLsui0FFFO6CCVs3Hg-Ypxd-Ty0UNIRvX93p0ccqKSE5INUMWVBzbp5hzcl49pTDoNCsCaklAPSeglgTUMYGquzyOmPaDs_9Vz19egU8HIIw-pkH_jam3qui5j8knPZqQFXt9xj-ewpOE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1841135512</pqid></control><display><type>article</type><title>Effects of Mitomycin C in Early Conjunctival Inflammation after Pterygium Surgery</title><source>Recercat</source><creator>da Costa Paula, Claudia ; Julio, Gemma ; Campos, Pamela ; Pujol, Pere ; Asaad, Mouafk</creator><creatorcontrib>da Costa Paula, Claudia ; Julio, Gemma ; Campos, Pamela ; Pujol, Pere ; Asaad, Mouafk</creatorcontrib><description>Purpose: The purpose of this study was to compare inflammatory events and graft characteristics 1 month and 6 months after conjunctival limbal autograft (CLAU) with and without intraoperative mitomycin C (MMC).
Methods: This study included 69 eyes of 69 patient's eyes with pterygium. Clinical data concerning patient demography, preoperative examination including pterygium morphology, recurrence clinical assessment, and complications after CLAU with (MMC+) and without (MMC−) intraoperative MMC were all registered at 1 month and 6 months after surgery.
Results: Thirty-five eyes were included in MMC+ and 34 in MMC−. Preoperative data were similar in both groups (Student's t test and Fisher's exact test; p > 0.05).
Thirty-four (49.6%) eyes in the whole sample showed at least one inflammatory complication at 1 month after surgery. MMC− group showed a significantly higher number of cases with complications (p < 0.001; Chi
2
test) (MMC+ 28.5%; MMC− 70.5%). No patients presented clinical recurrence at 1 month after surgery. The examination revealed a higher incidence of clinical hyperemia surrounding the surgical site and graft contraction on the host site on the MMC− group, both with statistical signification (p < 0.001; Chi
2
test). Although the hemorrhages were less frequent in the MMC− group, there were no significant differences between the two groups (p > 0.05; Chi
2
test). Pyogenic granuloma developed at the surgical site in three eyes (4.37%), two of those granulomas were at the MMC− group (p > 0.05).
Tendency for recurrences was significantly different between both groups (p = 0.0001; Fisher's exact test) at the end of 6 months. Thirteen (38%) eyes showed recurrence in MMC− and no cases were displayed in MMC+. Presence of at least 1 inflammatory event was only seen in 16 (23%) cases, all of them in MMC−. Specifically, 15 (44%) eyes showed hyperemia and one (3%) eye presented conjunctival hemorrhages. No new cases of pyogenic granuloma or graft contraction were seen at this time point in both groups. Hyperemia was the only specific event with significant differences between MMC− and MMC+ (p = 0.0001; Fisher's exact test) at 6 months after surgery.
Conclusion: The eyes receiving intraoperative MMC after CLAU seem to present less hyperemia and graft contraction after surgery than those that did not receive MMC as an adjuvant factor. Intraoperative MMC could be associated with a lower recurrence rates.</description><identifier>ISSN: 0271-3683</identifier><identifier>EISSN: 1460-2202</identifier><identifier>DOI: 10.1080/02713683.2016.1236965</identifier><identifier>PMID: 27854142</identifier><language>eng</language><publisher>England: Taylor & Francis</publisher><subject>Administration, Topical ; Adult ; Aged ; Antibiotics, Antineoplastic - administration & dosage ; Ciències de la salut ; Ciències de la visió ; Conjunctiva - pathology ; Conjunctiva - transplantation ; Conjunctival inflammation ; conjunctival limbal autograft ; Conjunctivitis ; Conjunctivitis - diagnosis ; Conjunctivitis - etiology ; Conjunctivitis - prevention & control ; Conjuntivitis ; Còrnia ; Female ; Follow-Up Studies ; Humans ; Inflammation - diagnosis ; Inflammation - etiology ; Inflammation - prevention & control ; Intraoperative Period ; Keratitis ; Malalties i defectes ; Male ; Medicina ; Middle Aged ; Mitomycin - administration & dosage ; Mitomycin C ; Oftalmologia ; Ophthalmologic Surgical Procedures - adverse effects ; Optometria ; Postoperative Complications - diagnosis ; Postoperative Complications - etiology ; Postoperative Complications - prevention & control ; Prospective Studies ; Pterygium ; Pterygium - surgery ; Queratitis ; Recurrence ; Time Factors ; Transplantation, Autologous ; Treatment Outcome ; Young Adult ; Àrees temàtiques de la UPC</subject><ispartof>Current eye research, 2017-05, Vol.42 (5), p.696-700</ispartof><rights>2017 Taylor & Francis 2017</rights><rights>info:eu-repo/semantics/openAccess <a href="http://creativecommons.org/licenses/by-nc-nd/3.0/es/">http://creativecommons.org/licenses/by-nc-nd/3.0/es/</a></rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-b4887391468d9355a8d3e3efd4d2e61d3c83af60824147e0404dd308b49e25303</citedby><cites>FETCH-LOGICAL-c455t-b4887391468d9355a8d3e3efd4d2e61d3c83af60824147e0404dd308b49e25303</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,777,882,26955</link.rule.ids><linktorsrc>$$Uhttps://recercat.cat/handle/2072/270252$$EView_record_in_Consorci_de_Serveis_Universitaris_de_Catalunya_(CSUC)$$FView_record_in_$$GConsorci_de_Serveis_Universitaris_de_Catalunya_(CSUC)$$Hfree_for_read</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27854142$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>da Costa Paula, Claudia</creatorcontrib><creatorcontrib>Julio, Gemma</creatorcontrib><creatorcontrib>Campos, Pamela</creatorcontrib><creatorcontrib>Pujol, Pere</creatorcontrib><creatorcontrib>Asaad, Mouafk</creatorcontrib><title>Effects of Mitomycin C in Early Conjunctival Inflammation after Pterygium Surgery</title><title>Current eye research</title><addtitle>Curr Eye Res</addtitle><description>Purpose: The purpose of this study was to compare inflammatory events and graft characteristics 1 month and 6 months after conjunctival limbal autograft (CLAU) with and without intraoperative mitomycin C (MMC).
Methods: This study included 69 eyes of 69 patient's eyes with pterygium. Clinical data concerning patient demography, preoperative examination including pterygium morphology, recurrence clinical assessment, and complications after CLAU with (MMC+) and without (MMC−) intraoperative MMC were all registered at 1 month and 6 months after surgery.
Results: Thirty-five eyes were included in MMC+ and 34 in MMC−. Preoperative data were similar in both groups (Student's t test and Fisher's exact test; p > 0.05).
Thirty-four (49.6%) eyes in the whole sample showed at least one inflammatory complication at 1 month after surgery. MMC− group showed a significantly higher number of cases with complications (p < 0.001; Chi
2
test) (MMC+ 28.5%; MMC− 70.5%). No patients presented clinical recurrence at 1 month after surgery. The examination revealed a higher incidence of clinical hyperemia surrounding the surgical site and graft contraction on the host site on the MMC− group, both with statistical signification (p < 0.001; Chi
2
test). Although the hemorrhages were less frequent in the MMC− group, there were no significant differences between the two groups (p > 0.05; Chi
2
test). Pyogenic granuloma developed at the surgical site in three eyes (4.37%), two of those granulomas were at the MMC− group (p > 0.05).
Tendency for recurrences was significantly different between both groups (p = 0.0001; Fisher's exact test) at the end of 6 months. Thirteen (38%) eyes showed recurrence in MMC− and no cases were displayed in MMC+. Presence of at least 1 inflammatory event was only seen in 16 (23%) cases, all of them in MMC−. Specifically, 15 (44%) eyes showed hyperemia and one (3%) eye presented conjunctival hemorrhages. No new cases of pyogenic granuloma or graft contraction were seen at this time point in both groups. Hyperemia was the only specific event with significant differences between MMC− and MMC+ (p = 0.0001; Fisher's exact test) at 6 months after surgery.
Conclusion: The eyes receiving intraoperative MMC after CLAU seem to present less hyperemia and graft contraction after surgery than those that did not receive MMC as an adjuvant factor. Intraoperative MMC could be associated with a lower recurrence rates.</description><subject>Administration, Topical</subject><subject>Adult</subject><subject>Aged</subject><subject>Antibiotics, Antineoplastic - administration & dosage</subject><subject>Ciències de la salut</subject><subject>Ciències de la visió</subject><subject>Conjunctiva - pathology</subject><subject>Conjunctiva - transplantation</subject><subject>Conjunctival inflammation</subject><subject>conjunctival limbal autograft</subject><subject>Conjunctivitis</subject><subject>Conjunctivitis - diagnosis</subject><subject>Conjunctivitis - etiology</subject><subject>Conjunctivitis - prevention & control</subject><subject>Conjuntivitis</subject><subject>Còrnia</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Inflammation - diagnosis</subject><subject>Inflammation - etiology</subject><subject>Inflammation - prevention & control</subject><subject>Intraoperative Period</subject><subject>Keratitis</subject><subject>Malalties i defectes</subject><subject>Male</subject><subject>Medicina</subject><subject>Middle Aged</subject><subject>Mitomycin - administration & dosage</subject><subject>Mitomycin C</subject><subject>Oftalmologia</subject><subject>Ophthalmologic Surgical Procedures - adverse effects</subject><subject>Optometria</subject><subject>Postoperative Complications - diagnosis</subject><subject>Postoperative Complications - etiology</subject><subject>Postoperative Complications - prevention & control</subject><subject>Prospective Studies</subject><subject>Pterygium</subject><subject>Pterygium - surgery</subject><subject>Queratitis</subject><subject>Recurrence</subject><subject>Time Factors</subject><subject>Transplantation, Autologous</subject><subject>Treatment Outcome</subject><subject>Young Adult</subject><subject>Àrees temàtiques de la UPC</subject><issn>0271-3683</issn><issn>1460-2202</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>XX2</sourceid><recordid>eNp9kUtv1DAUhS0EotOWn9DKSzaZXr8Szw40GmilVoAoa8vjR-UqiYvtgPLvcTRTuuvC1w99594jH4QuCKwJSLgC2hHWSramQNo1oazdtOINWhHeQkMp0LdotTDNAp2g05wfAZYH_h6d0E4KTjhdoR87750pGUeP70KJw2zCiLe4lp1O_Yy3cXycRlPCH93jm9H3ehh0CXHE2heX8Pda5ocwDfjnlB7q-Ry987rP7sNxP0O_vuzut9fN7bevN9vPt43hQpRmz6Xs2KbalXbDhNDSMsect9xS1xLLjGTatyBpNdo54MCtZSD3fOOoYMDOEDn0NXkyKjnjktFFRR1eLsui0FFFO6CCVs3Hg-Ypxd-Ty0UNIRvX93p0ccqKSE5INUMWVBzbp5hzcl49pTDoNCsCaklAPSeglgTUMYGquzyOmPaDs_9Vz19egU8HIIw-pkH_jam3qui5j8knPZqQFXt9xj-ewpOE</recordid><startdate>20170504</startdate><enddate>20170504</enddate><creator>da Costa Paula, Claudia</creator><creator>Julio, Gemma</creator><creator>Campos, Pamela</creator><creator>Pujol, Pere</creator><creator>Asaad, Mouafk</creator><general>Taylor & Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>XX2</scope></search><sort><creationdate>20170504</creationdate><title>Effects of Mitomycin C in Early Conjunctival Inflammation after Pterygium Surgery</title><author>da Costa Paula, Claudia ; Julio, Gemma ; Campos, Pamela ; Pujol, Pere ; Asaad, Mouafk</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-b4887391468d9355a8d3e3efd4d2e61d3c83af60824147e0404dd308b49e25303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Administration, Topical</topic><topic>Adult</topic><topic>Aged</topic><topic>Antibiotics, Antineoplastic - administration & dosage</topic><topic>Ciències de la salut</topic><topic>Ciències de la visió</topic><topic>Conjunctiva - pathology</topic><topic>Conjunctiva - transplantation</topic><topic>Conjunctival inflammation</topic><topic>conjunctival limbal autograft</topic><topic>Conjunctivitis</topic><topic>Conjunctivitis - diagnosis</topic><topic>Conjunctivitis - etiology</topic><topic>Conjunctivitis - prevention & control</topic><topic>Conjuntivitis</topic><topic>Còrnia</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Inflammation - diagnosis</topic><topic>Inflammation - etiology</topic><topic>Inflammation - prevention & control</topic><topic>Intraoperative Period</topic><topic>Keratitis</topic><topic>Malalties i defectes</topic><topic>Male</topic><topic>Medicina</topic><topic>Middle Aged</topic><topic>Mitomycin - administration & dosage</topic><topic>Mitomycin C</topic><topic>Oftalmologia</topic><topic>Ophthalmologic Surgical Procedures - adverse effects</topic><topic>Optometria</topic><topic>Postoperative Complications - diagnosis</topic><topic>Postoperative Complications - etiology</topic><topic>Postoperative Complications - prevention & control</topic><topic>Prospective Studies</topic><topic>Pterygium</topic><topic>Pterygium - surgery</topic><topic>Queratitis</topic><topic>Recurrence</topic><topic>Time Factors</topic><topic>Transplantation, Autologous</topic><topic>Treatment Outcome</topic><topic>Young Adult</topic><topic>Àrees temàtiques de la UPC</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>da Costa Paula, Claudia</creatorcontrib><creatorcontrib>Julio, Gemma</creatorcontrib><creatorcontrib>Campos, Pamela</creatorcontrib><creatorcontrib>Pujol, Pere</creatorcontrib><creatorcontrib>Asaad, Mouafk</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Recercat</collection><jtitle>Current eye research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>da Costa Paula, Claudia</au><au>Julio, Gemma</au><au>Campos, Pamela</au><au>Pujol, Pere</au><au>Asaad, Mouafk</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of Mitomycin C in Early Conjunctival Inflammation after Pterygium Surgery</atitle><jtitle>Current eye research</jtitle><addtitle>Curr Eye Res</addtitle><date>2017-05-04</date><risdate>2017</risdate><volume>42</volume><issue>5</issue><spage>696</spage><epage>700</epage><pages>696-700</pages><issn>0271-3683</issn><eissn>1460-2202</eissn><abstract>Purpose: The purpose of this study was to compare inflammatory events and graft characteristics 1 month and 6 months after conjunctival limbal autograft (CLAU) with and without intraoperative mitomycin C (MMC).
Methods: This study included 69 eyes of 69 patient's eyes with pterygium. Clinical data concerning patient demography, preoperative examination including pterygium morphology, recurrence clinical assessment, and complications after CLAU with (MMC+) and without (MMC−) intraoperative MMC were all registered at 1 month and 6 months after surgery.
Results: Thirty-five eyes were included in MMC+ and 34 in MMC−. Preoperative data were similar in both groups (Student's t test and Fisher's exact test; p > 0.05).
Thirty-four (49.6%) eyes in the whole sample showed at least one inflammatory complication at 1 month after surgery. MMC− group showed a significantly higher number of cases with complications (p < 0.001; Chi
2
test) (MMC+ 28.5%; MMC− 70.5%). No patients presented clinical recurrence at 1 month after surgery. The examination revealed a higher incidence of clinical hyperemia surrounding the surgical site and graft contraction on the host site on the MMC− group, both with statistical signification (p < 0.001; Chi
2
test). Although the hemorrhages were less frequent in the MMC− group, there were no significant differences between the two groups (p > 0.05; Chi
2
test). Pyogenic granuloma developed at the surgical site in three eyes (4.37%), two of those granulomas were at the MMC− group (p > 0.05).
Tendency for recurrences was significantly different between both groups (p = 0.0001; Fisher's exact test) at the end of 6 months. Thirteen (38%) eyes showed recurrence in MMC− and no cases were displayed in MMC+. Presence of at least 1 inflammatory event was only seen in 16 (23%) cases, all of them in MMC−. Specifically, 15 (44%) eyes showed hyperemia and one (3%) eye presented conjunctival hemorrhages. No new cases of pyogenic granuloma or graft contraction were seen at this time point in both groups. Hyperemia was the only specific event with significant differences between MMC− and MMC+ (p = 0.0001; Fisher's exact test) at 6 months after surgery.
Conclusion: The eyes receiving intraoperative MMC after CLAU seem to present less hyperemia and graft contraction after surgery than those that did not receive MMC as an adjuvant factor. Intraoperative MMC could be associated with a lower recurrence rates.</abstract><cop>England</cop><pub>Taylor & Francis</pub><pmid>27854142</pmid><doi>10.1080/02713683.2016.1236965</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | ISSN: 0271-3683 |
| ispartof | Current eye research, 2017-05, Vol.42 (5), p.696-700 |
| issn | 0271-3683 1460-2202 |
| language | eng |
| recordid | cdi_csuc_recercat_oai_recercat_cat_2072_270252 |
| source | Recercat |
| subjects | Administration, Topical Adult Aged Antibiotics, Antineoplastic - administration & dosage Ciències de la salut Ciències de la visió Conjunctiva - pathology Conjunctiva - transplantation Conjunctival inflammation conjunctival limbal autograft Conjunctivitis Conjunctivitis - diagnosis Conjunctivitis - etiology Conjunctivitis - prevention & control Conjuntivitis Còrnia Female Follow-Up Studies Humans Inflammation - diagnosis Inflammation - etiology Inflammation - prevention & control Intraoperative Period Keratitis Malalties i defectes Male Medicina Middle Aged Mitomycin - administration & dosage Mitomycin C Oftalmologia Ophthalmologic Surgical Procedures - adverse effects Optometria Postoperative Complications - diagnosis Postoperative Complications - etiology Postoperative Complications - prevention & control Prospective Studies Pterygium Pterygium - surgery Queratitis Recurrence Time Factors Transplantation, Autologous Treatment Outcome Young Adult Àrees temàtiques de la UPC |
| title | Effects of Mitomycin C in Early Conjunctival Inflammation after Pterygium Surgery |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T06%3A08%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_XX2&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20Mitomycin%20C%20in%20Early%20Conjunctival%20Inflammation%20after%20Pterygium%20Surgery&rft.jtitle=Current%20eye%20research&rft.au=da%20Costa%20Paula,%20Claudia&rft.date=2017-05-04&rft.volume=42&rft.issue=5&rft.spage=696&rft.epage=700&rft.pages=696-700&rft.issn=0271-3683&rft.eissn=1460-2202&rft_id=info:doi/10.1080/02713683.2016.1236965&rft_dat=%3Cproquest_XX2%3E1841135512%3C/proquest_XX2%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1841135512&rft_id=info:pmid/27854142&rfr_iscdi=true |